8 News & Press Releases found

Restech Srl news

Come and see our products RESMON PRO FULL and DIARY at the next ERS 2018 annual conference in Paris!

We are proud to announce that both our product RESMON PRO FULL and DIARY will be present at the next ERS 2018 Annual Conference that will be held in Paris from the 15th to the 18th of September 2018. The products will be displayed at the booths of our international distributors:

RESMON PRO FULL: MGC/Medisoft, booth F02
RESMON PRO DIARY: VIVISOL, booth A06

Sep. 4, 2018

A new paper on the use of Resmon Pro Full to evaluate the effects of airway clearance on patients with cystic fibrosis is available online!

Prof Wallaert and its research group in Belgium used the RESMON PRO FULL to investigate the effects of autogenic drainage technique on ventilatory mechanics in adult with cystic fibrosis. According to the authors: “The FOT opens up new avenues of mechanistic research to understand the pathophysiological effects of airway clearance physiotherapy in CF.”.

The ful paper is available here:

Jun. 12, 2018

ERCA-JIVD 2018 Satellite Symposium: New Non-invasive COPD Screening of EFL Within Home Therapy now available online!

During this satellite symposium, held at the latest ERCA (European Respiratory Care Association) and JIVD (Journées Internationales de Ventilation à Domicile) congress, Prof. Peter Calverley, Prof. Raffaele Dellacà, dr. Romano and prof. David White will walk you through:

the physiology of tidal Expiratory Flow Limitation (EFL)
the advantages of using FOT to detect EFL
the clinical importance of its detection.

You can view

Apr. 23, 2018

Restech announces the clinical validation of the Resmon Pro Diary to remotely monitor COPD at home.

The CHROMED trial, one of the largest clinical trial using FOT to monitor remotely COPD patients and prevent exacerbation has now been published on the American Journal of Respiratory and Critical care medicine!

Using the RESMON PRO DIARY (the home version of the well proven, hospital, clinical unit, the RESMON PRO FULL), 312 patients from 5 different European countries have been successfully monitored for 9 months and their treatment adjusted according to the alerts automatical

Apr. 22, 2018

Restech will be present at the next screening day organized by the Italian League against Tumor (LILT)

Saturday 23rd of September 2017 RESTECH will participate with 2 RESMON PRO FULL devices to the “Spirometry day” organized by the Italian League against Tumor (LILT) in Bolzano. Anyone interested in having a free screening of his/her lung function can come and visit us at Piazza della Mostra from 9:00 until 13:00!

Sep. 18, 2017

RESTECH and VIVISOL together to bring innovative monitoring at home of COPD patients

RESTECH srl and VIVISOL has established a long-term commercial partnership to commercialize the RESMON PRO DIARY and its innovative algorithm for the detection of the risk of exacerbation in COPD patients. Thanks to this collaboration RESTECH will be able to consolidate its operative know-how and bring the latest innovations in home monitoring directly in the homes of COPD patients of the main countries of Europe.

Feb. 15, 2017

RESMON PRO FULL win the ERS POINT award 2016

RESMON PRO FULL has been awarded, between 18 nominees, by the European Respiratory Society with the POINT (Product of Outstanding Interest) award in the category of “Diagnostic Devices”. Three were the reasons why the award was assigned: 1) it has a “simple” verification device to improve quality; 2) automatic quality control breath-by breath; 3) its easy and intuitive way of displaying the results of the test.

Sep. 7, 2016

CHROMED trial completed successfully

Restech, in its role of technical manager and together with all the partner of the project, successfully concluded the CHROMED trial.

With 312 patients enrolled and studied for 9 months by 6 clinical centers in 5 EU Countries, CHROMED has been the largest international multi-center randomized control trial evaluating the effectiveness of an integrated telec

Apr. 1, 2016